GLP-RETA KIT

Retatrutide Peptide Research Kit – Triple-Agonist (GLP-1, GIP, Glucagon)

Retatrutide is an advanced triple-agonist peptide available in 10mg, 15mg, and 20mg sterile vials, designed exclusively for laboratory and in vitro research. By simultaneously targeting GLP-1, GIP, and glucagon receptors, Retatrutide represents a powerful new tool in the study of metabolic regulation, glucose balance, and thermogenesis.

🧬 Mechanism of Action

• Activates GLP-1 and GIP receptors to enhance insulin secretion
• Stimulates glucagon pathways to support energy expenditure
• Suppresses appetite, slows gastric emptying, and increases fat oxidation

🔍 Research Highlights

• Triple Receptor Agonism: Engages GLP-1, GIP, and glucagon pathways for synergistic effects
• Weight Loss & Metabolism: Supports studies on appetite suppression and metabolic rate increase
• Glucose Regulation: Enhances insulin sensitivity and glycemic control in metabolic models

🔬 Research Applications

• Advanced metabolic disorder studies
• Weight management and thermogenesis research
• Triple-agonist receptor interaction studies

🚫 For Research Use Only

This product is strictly intended for research purposes only. It is not for human or animal consumption. By purchasing, you confirm that you are a qualified researcher handling peptides in accordance with all applicable regulations and ethical standards.